In the realm of medical imaging, the early detection of kidney issues, particularly renal cell hydronephrosis, holds immense importance. Traditionally, the identification of such conditions within ultrasound images has relied on manual analysis, a labor-intensive and error-prone process. However, in recent years, the emergence of deep learning-based algorithms has paved the way for automation in this domain. This study aims to harness the power of deep learning models to autonomously detect renal cell hydronephrosis in ultrasound images taken in close proximity to the kidneys. State-of-the-art architectures, including VGG16, ResNet50, InceptionV3, and the innovative Novel DCNN, were put to the test and subjected to rigorous comparisons. The performance of each model was meticulously evaluated, employing metrics such as F1 score, accuracy, precision, and recall. The results paint a compelling picture. The Novel DCNN model outshines its peers, boasting an impressive accuracy rate of 99.8%. In the same arena, InceptionV3 achieved a notable 90% accuracy, ResNet50 secured 89%, and VGG16 reached 85%. These outcomes underscore the Novel DCNN's prowess in the realm of renal cell hydronephrosis detection within ultrasound images. Moreover, this study offers a detailed view of each model's performance through confusion matrices, shedding light on their abilities to categorize true positives, true negatives, false positives, and false negatives. In this regard, the Novel DCNN model exhibits remarkable proficiency, minimizing both false positives and false negatives. In conclusion, this research underscores the Novel DCNN model's supremacy in automating the detection of renal cell hydronephrosis in ultrasound images. With its exceptional accuracy and minimal error rates, this model stands as a promising tool for healthcare professionals, facilitating early-stage diagnosis and treatment. Furthermore, the model's convergence rate and accuracy hold potential for enhancement through further exploration, including testing on larger and more diverse datasets and investigating diverse optimization strategies.
A pathological complete response to neoadjuvant chemoradiotherapy offers patients with rectal cancer that has advanced locally the highest chance of survival. However, there isn't yet a valid prediction model available. An efficient feature extraction technique is also required to increase a prediction model's precision. CDAS (cancer data access system) program is a great place to look for cancer along with images or biospecimens. In this study, we look at data from the CDAS system, specifically Bowel cancer (colorectal cancer) datasets. This study suggested a survival prediction method for rectal cancer. In addition, determines which deep learning algorithm works best by comparing their performance in terms of prediction accuracy. The initial job that leads to correct findings is corpus cleansing. Moving forward, the data pre-processing activity will be performed, which will comprise "exploratory data analysis and pruning and normalization or experimental study of data, which is required to obtain data features to design the model for cancer detection at an early stage." Aside from that, the data corpus is separated into two sub-corpora: training data and test data, which will be utilized to assess the correctness of the constructed model. This study will compare our auto-encoder accuracy to that of other deep learning algorithms, such as ANN, CNN, and RBM, before implementing the suggested methodology and displaying the model's accuracy graphically after the suggested new methodology or algorithm for patients with rectal cancer. Various criteria, including true positive rate, ROC curve, and accuracy scores, are used in the experiments to determine the model's high accuracy. In the end, we determine the accuracy score for each model. The outcomes of the simulation demonstrated that rectal cancer patients may be estimated using prediction models. It is shown that variational deep encoders have excellent accuracy of 94% in this cancer prediction and 95% for ROC curve regions. The findings demonstrate that automated prediction algorithms are capable of properly estimating rectal cancer patients’ chances of survival. The best results, with 95% accuracy, were generated by deep autoencoders.